Prostate cancer risk, screening and management in patients with germline BRCA1_2 mutations, P. Rajwa, PL 13views Videos You may also like Can we make NMIBC treatment better tolerated and cheaper, B. Pradere, FR 16views Videos Can we treat beyond guidelines, M. Schmidinger, AUT 14views Videos Circulating tumor DNA for biomarker dectection in patients with CRPC – ready for prime time, T. Bauernhofer, AUT 7views Videos Enbloc for NMIBC – Where we stand now, D. Enikeev, RU 14views Videos Essentials of pheochromocytoma and adrenocortocal carcinoma, M. Remzi, AUT 8views Videos 16:11 How to best use current drugs/ treatment sequencing and combinations for metastatic castration resistant prostate cancer, G. Kramer, AUT 14views Videos HPV vaccination – a gender neutral cancer prevention strategy, E. Joura, AUT 7views Videos Intensifiing treatments for mHSPC, I. Heidegger, AUT 10views Videos Is there a role for triplet therapy in the first-line setting of mRCC, M. Schmidinger, AT 7views Videos Management of clinically node positive prostate cancer, J. Bektic, AUT 11views Videos 123»Page 1 of 3
